| 1 | GMRAFN5 ;HIRMFO/WAA-FDA MEDWATCH FORM ;11/30/95 15:36
|
---|
| 2 | ;;4.0;Adverse Reaction Tracking;;Mar 29, 1996
|
---|
| 3 | S GMRAX=$G(^GMR(120.85,GMRAPA1,"RPT"))
|
---|
| 4 | W ?66,"|1. Name, address & phone #: " I GMRAPG1=1 W $P(GMRAX,U)
|
---|
| 5 | W !,$E(LINE2,1,66),"|" I GMRAPG1=1 W $E($P(GMRAX,U,2)_" "_$P(GMRAX,U,3)_" "_$P(GMRAX,U,4),1,63)
|
---|
| 6 | W !,?66,"|" I GMRAPG1=1 W $E($P(GMRAX,U,5),1,63) W:$P(GMRAX,U,6)'="" ", ",$P(^DIC(5,$P(GMRAX,U,6),0),U)," " W:$P(GMRAX,U,7)'="" $P(GMRAX,U,7) W " ",$P(GMRAX,U,8)
|
---|
| 7 | W !,"Mail to: MedWatch or FAX to:",?66,"|",$E(LINE1,68,131)
|
---|
| 8 | W !," 5600 Fishers Lane 1-800-FDA-0178",?66,"|2. Health professional? |3. Occupation |4. Reported to Mfr."
|
---|
| 9 | W !," Rockville, MD 20852-9787",?66,"|"
|
---|
| 10 | I GMRAPG1=1 W ?70,"[",$S($P(GMRAX,U,9)="n":"NO",$P(GMRAX,U,9)="y":"YES",1:" "),"]"
|
---|
| 11 | W ?91,"|" I GMRAPG1=1 W $E($P(GMRAX,U,11),1,14)
|
---|
| 12 | W ?106,"|" I GMRAPG1=1 W ?110,"[",$S($P($G(^GMR(120.85,GMRAPA1,"PTC1")),U,7)'="":"YES",1:"NO"),"]"
|
---|
| 13 | W !,?66,"|",$E(LINE1,68,131)
|
---|
| 14 | W !,?66,"|5. If you don't want your identity disclosed to the Manufacturer,"
|
---|
| 15 | W !,?66,"| place an ""X"" in the box.["
|
---|
| 16 | I GMRAPG1=1 W $S($P(GMRAX,U,10)="n":"X",1:" "),"]"
|
---|
| 17 | I GMRAPG1'=1 W " ]"
|
---|
| 18 | W !,"FDA Form 3500",?66,"|",$E(LINE2,68,131)
|
---|
| 19 | W !!,"Submission of a report does not constitute an admission that medical personnel or the product caused or contributed to the event."
|
---|
| 20 | W @IOF
|
---|
| 21 | Q
|
---|
| 22 | CONCO ;PRINT CONCOMITANT DRUG DATA
|
---|
| 23 | S GMRAX=$G(^TMP($J,"GMR","C",GMRACCT)) K ^TMP($J,"GMR","C",GMRACCT)
|
---|
| 24 | W " ",$P(GMRAX,U)," " I $P(GMRAX,U,2)'="" W $E($P(GMRAX,U,2),4,5),"/",$E($P(GMRAX,U,2),6,7),"/",$E($P(GMRAX,U,2),2,3)
|
---|
| 25 | I $P(GMRAX,U,3)'="" W "-",$E($P(GMRAX,U,3),4,5),"/",$E($P(GMRAX,U,3),6,7),"/",$E($P(GMRAX,U,3),2,3)
|
---|
| 26 | K GMRAX
|
---|
| 27 | I '$D(^TMP($J,"GMR","C",(GMRACCT+1))) S GMRANOC=0
|
---|
| 28 | Q
|
---|